About i-SENS
A global in vitro diagnostics company that researches, develops, and produces products to support human health by leveraging advanced biosensor and electrochemical technologies.
With many years of experience in technology development, along with patents and research capabilities, i-SENS continues to develop and launch pioneering, easy-to-use products.
Our blood glucose monitoring devices have been welcomed by customers in over 110 countries, including Korea, the United States, and across Europe, thanks to their intuitive design and accuracy. In addition, we, i-SENS, lead the diagnostic market with a diverse product portfolio, including electrolyte analyzers, blood gas analyzers, immunochemistry analyzers, and immunoassay analyzers, which are point-of-care systems capable of using whole blood.
In September 2023 in particular, we launched CareSense Air, the first continuous blood glucose monitoring device developed in Korea, providing an innovative blood glucose management solution. We are further strengthening our global position by entering overseas markets, starting with Europe in 2024. i-SENS will always keep in mind our foundational philosophy of ‘developing and selling diagnostic products based on cutting-edge technologies to contribute to human health’ and we aim to manufacture world’s best products through seamless research and investment in core technologies.
Company Information
Established
Revenue
As of the end of 2024
Total assets
As of the end of 2024
Investment in R&D
As of the end of 2024
Number of business locations
5 domestic, 9 overseas
i-SENS Family
As of the end of 2024
Blood Glucose
Monitoring SystemContinuous Glucose
Monitoring SystemPoint of Care System
Veterinary Care System
0
0
billion KRW
0
billion KRW
0
billion KRW
Total
0
0
employees
CareSens is a self-monitoring blood glucose system that meets the accuracy, hematocrit, and interference
criteria specified in ISO 15197:2013.
CareSens Air, the first domestically produced continuous glucose monitoring system with CE certification,
provides real-time blood glucose data and trend analysis.
With cutting-edge whole blood-based technology, our POCT diagnostic solutions ensure patient-centered care
with uncompromising precision.
By delivering quick and accurate diagnostics, we advance the care of companion animals.
We use cookies to improve how our website works and to enhance your experience.